Pediatric COVID-19 Vaccines
Award Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75D30123D16649
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Novavax Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30123D16649 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services awarded a $145 million contract to NOVAVAX INC on June 7, 2023 for pediatric COVID-19 vaccines. The awarded contract number 75D30123D16649 is to provide COVID-19 vaccines for children, with NOVAVAX INC receiving $145 million under the terms of the contract. The award was made without a set-aside designation by the agency.
Notice text
Awarded contract 75D30123D16649 to NOVAVAX INC for 145000000.00 on 2023-06-07.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pediatric COVID-19 Vaccines | Limited / Sole Source Justification | |
| Pediatric COVID-19 Vaccines | Limited / Sole Source Justification | |
| This notice | Award Notice | |
| Pediatric COVID-19 Vaccines | Award Notice | |
| Pediatric COVID-19 Vaccines | Award Notice | |
| Pediatric COVID-19 Vaccines | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity